SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-015400
Filing Date
2015-01-21
Accepted
2015-01-21 06:05:04
Documents
1
Effectiveness Date
2015-01-21

Document Format Files

Seq Description Document Type Size
1 DEFA14A d854806ddefa14a.htm DEFA14A 24444
  Complete submission text file 0001193125-15-015400.txt   25550
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-12465 | Film No.: 15537397
SIC: 2834 Pharmaceutical Preparations